Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus

NCT00607087 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

289

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin glulisine
DRUG: Insulin lispro
DRUG: Insulin aspart

Sponsor

Sanofi